InvestorsHub Logo
Followers 276
Posts 32701
Boards Moderated 0
Alias Born 11/14/2013

Re: rene33 post# 3578

Thursday, 01/23/2014 6:40:58 PM

Thursday, January 23, 2014 6:40:58 PM

Post# of 700554
Think of it this way Rene.

I'll start this by saying I hope all cancer drugs succeed.

However, look at all the amazing press BMY gets on Nivolumab. Take today's CNBC video for example. http://video.cnbc.com/gallery/?video=3000238816

or these articles:

Benefits Durable in Three Tumor Types, OncLive, August 19, 2013 [?]
Bristol-Myers shares jump on ‘beginning of the end of cancer’, MarketWatch, May 22, 2013 [?]

But now look more closely at the OS, PFS and Response Rates for this drug that is supposedly the "beginning of the end to cancer." They do not compare with DCVAX-L. Not even close. I pray for those taking that drug however, and maybe DCVAX-L compassionate use will also be an alternative for them. If DCVAX Direct results come back demonstrating tumor eradication….

The point is, small drug companies do not usually garner media attention like large pharma does.

BMY has a market cap around 88 billion, if we eventually get to that market cap, the price of our stock is too high for words….

However, you must stay within your own risk tolerance. This is biotech after all.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News